• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Covalent labeling and mass spectrometry reveal subtle higher order structural changes for antibody therapeutics.共价标记和质谱分析揭示抗体治疗药物的细微高级结构变化。
MAbs. 2019 Apr;11(3):463-476. doi: 10.1080/19420862.2019.1565748. Epub 2019 Feb 6.
2
Complementary Structural Information for Stressed Antibodies from Hydrogen-Deuterium Exchange and Covalent Labeling Mass Spectrometry.应激抗体的氢氘交换和共价标记质谱互补结构信息。
J Am Soc Mass Spectrom. 2021 May 5;32(5):1237-1248. doi: 10.1021/jasms.1c00072. Epub 2021 Apr 22.
3
Investigating Therapeutic Protein Structure with Diethylpyrocarbonate Labeling and Mass Spectrometry.利用焦碳酸二乙酯标记和质谱法研究治疗性蛋白质结构
Anal Chem. 2015 Oct 20;87(20):10627-34. doi: 10.1021/acs.analchem.5b03180. Epub 2015 Oct 1.
4
Covalent Labeling/Mass Spectrometry of Monoclonal Antibodies with Diethylpyrocarbonate: Reaction Kinetics for Ensuring Protein Structural Integrity.二乙基焦碳酸酯对单克隆抗体的共价标记/质谱分析:确保蛋白质结构完整性的反应动力学。
J Am Soc Mass Spectrom. 2020 Jun 3;31(6):1223-1232. doi: 10.1021/jasms.0c00067. Epub 2020 Apr 30.
5
Proteins Can Withstand More Extensive Labeling while Providing Accurate Structural Information in Covalent Labeling-Mass Spectrometry.蛋白质在共价标记-质谱法中可以承受更广泛的标记,同时提供准确的结构信息。
J Am Soc Mass Spectrom. 2024 May 1;35(5):1030-1039. doi: 10.1021/jasms.4c00043. Epub 2024 Apr 6.
6
Higher-Order Structure Influences the Kinetics of Diethylpyrocarbonate Covalent Labeling of Proteins.高级结构影响二乙基焦碳酸酯共价标记蛋白质的动力学。
J Am Soc Mass Spectrom. 2020 Mar 4;31(3):658-665. doi: 10.1021/jasms.9b00132. Epub 2020 Jan 27.
7
Site-Specific Structural Changes in Long-Term-Stressed Monoclonal Antibody Revealed with DEPC Covalent-Labeling and Quantitative Mass Spectrometry.通过DEPC共价标记和定量质谱揭示长期应激单克隆抗体的位点特异性结构变化
Pharmaceuticals (Basel). 2023 Oct 5;16(10):1418. doi: 10.3390/ph16101418.
8
Investigating Protein-Nucleic Acid Binding Interactions with Diethylpyrocarbonate Covalent Labeling-Mass Spectrometry.利用二乙基焦碳酸酯共价标记-质谱法研究蛋白质-核酸相互作用。
J Am Soc Mass Spectrom. 2024 Oct 2;35(10):2272-2275. doi: 10.1021/jasms.4c00285. Epub 2024 Aug 29.
9
Synergistic Structural Information from Covalent Labeling and Hydrogen-Deuterium Exchange Mass Spectrometry for Protein-Ligand Interactions.共价标记和氢氘交换质谱联用获取蛋白质-配体相互作用的协同结构信息。
Anal Chem. 2019 Dec 3;91(23):15248-15254. doi: 10.1021/acs.analchem.9b04257. Epub 2019 Nov 12.
10
Diethylpyrocarbonate-Based Covalent Labeling Mass Spectrometry of Protein Interactions in a Membrane Complex System.基于二乙基焦碳酸酯的共价标记质谱法用于膜复合物系统中蛋白质相互作用的研究。
J Am Soc Mass Spectrom. 2023 Jan 4;34(1):82-91. doi: 10.1021/jasms.2c00262. Epub 2022 Dec 7.

引用本文的文献

1
Mass Spectrometry-Driven Epitope Mapping: Application of Diethylpyrocarbonate Covalent Labeling for the Immunotherapeutic Target Programmed Cell Death Protein 1.质谱驱动的表位作图:焦碳酸二乙酯共价标记在免疫治疗靶点程序性细胞死亡蛋白1中的应用
J Am Soc Mass Spectrom. 2025 Jul 2;36(7):1480-1492. doi: 10.1021/jasms.5c00070. Epub 2025 Jun 20.
2
Mapping conformational changes on bispecific antigen-binding biotherapeutic by covalent labeling and mass spectrometry.通过共价标记和质谱法绘制双特异性抗原结合生物治疗药物的构象变化
J Pharm Anal. 2024 Aug;14(8):100966. doi: 10.1016/j.jpha.2024.100966. Epub 2024 Mar 16.
3
Evaluating Chemical Footprinting-Induced Perturbation of Protein Higher Order Structure.评估化学足迹诱导的蛋白质高级结构扰动。
Anal Chem. 2024 Jun 11;96(23):9693-9703. doi: 10.1021/acs.analchem.4c01735. Epub 2024 May 30.
4
Proteins Can Withstand More Extensive Labeling while Providing Accurate Structural Information in Covalent Labeling-Mass Spectrometry.蛋白质在共价标记-质谱法中可以承受更广泛的标记,同时提供准确的结构信息。
J Am Soc Mass Spectrom. 2024 May 1;35(5):1030-1039. doi: 10.1021/jasms.4c00043. Epub 2024 Apr 6.
5
Site-Specific Structural Changes in Long-Term-Stressed Monoclonal Antibody Revealed with DEPC Covalent-Labeling and Quantitative Mass Spectrometry.通过DEPC共价标记和定量质谱揭示长期应激单克隆抗体的位点特异性结构变化
Pharmaceuticals (Basel). 2023 Oct 5;16(10):1418. doi: 10.3390/ph16101418.
6
Diethylpyrocarbonate-Based Covalent Labeling Mass Spectrometry of Protein Interactions in a Membrane Complex System.基于二乙基焦碳酸酯的共价标记质谱法用于膜复合物系统中蛋白质相互作用的研究。
J Am Soc Mass Spectrom. 2023 Jan 4;34(1):82-91. doi: 10.1021/jasms.2c00262. Epub 2022 Dec 7.
7
Complementary Structural Information for Antibody-Antigen Complexes from Hydrogen-Deuterium Exchange and Covalent Labeling Mass Spectrometry.基于氘氢交换和共价标记质谱的抗体-抗原复合物互补结构信息。
J Am Soc Mass Spectrom. 2022 Jul 6;33(7):1303-1314. doi: 10.1021/jasms.2c00108. Epub 2022 Jun 15.
8
Covalent Labeling-Mass Spectrometry Provides a Molecular Understanding of Noncovalent Polymer-Protein Complexation.共价标记-质谱法为非共价聚合物-蛋白质复合物提供了分子水平的理解。
ACS Biomater Sci Eng. 2022 Jun 13;8(6):2489-2499. doi: 10.1021/acsbiomaterials.2c00125. Epub 2022 May 24.
9
Mass Spectrometry Methods for Measuring Protein Stability.质谱法测量蛋白质稳定性。
Chem Rev. 2022 Apr 27;122(8):7690-7719. doi: 10.1021/acs.chemrev.1c00857. Epub 2022 Mar 22.
10
Distinguishing Histidine Tautomers in Proteins Using Covalent Labeling-Mass Spectrometry.使用共价标记-质谱法区分蛋白质中的组氨酸互变异构体。
Anal Chem. 2022 Jan 18;94(2):1003-1010. doi: 10.1021/acs.analchem.1c03902. Epub 2021 Dec 28.

本文引用的文献

1
Antibodies to watch in 2019.2019 年值得关注的抗体药物
MAbs. 2019 Feb/Mar;11(2):219-238. doi: 10.1080/19420862.2018.1556465. Epub 2018 Dec 22.
2
New 2017 Data and Statistics for Pharmaceutical Products.2017年药品新数据与统计信息
ACS Chem Neurosci. 2018 Jul 18;9(7):1518-1519. doi: 10.1021/acschemneuro.8b00320.
3
Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues.蛋白类药物的后期处理和管理以及潜在的不稳定性问题。
J Pharm Sci. 2018 Aug;107(8):2013-2019. doi: 10.1016/j.xphs.2018.04.005. Epub 2018 Apr 14.
4
Covalent labeling-mass spectrometry with non-specific reagents for studying protein structure and interactions.利用非特异性试剂进行共价标记-质谱法研究蛋白质结构和相互作用。
Methods. 2018 Jul 15;144:79-93. doi: 10.1016/j.ymeth.2018.04.002. Epub 2018 Apr 7.
5
Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.安进生物类似药 ABP 215 与贝伐珠单抗的分析和功能相似性。
MAbs. 2018 May/Jun;10(4):678-691. doi: 10.1080/19420862.2018.1452580. Epub 2018 Apr 20.
6
Analytical Comparability Assessments of 5 Recombinant CRM Proteins From Different Manufacturers and Expression Systems.不同厂家及表达系统的 5 种重组 CRM 蛋白的分析可比性评估
J Pharm Sci. 2018 Jul;107(7):1806-1819. doi: 10.1016/j.xphs.2018.03.002. Epub 2018 Mar 8.
7
Analytical comparability study of recombinant monoclonal antibody therapeutics.重组单克隆抗体治疗药物的分析可比性研究。
MAbs. 2018 May/Jun;10(4):513-538. doi: 10.1080/19420862.2018.1438797. Epub 2018 Mar 20.
8
Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product.利妥昔单抗生物类似药 CT-P10 与参比制剂的分析相似性评估。
MAbs. 2018 Apr;10(3):380-396. doi: 10.1080/19420862.2018.1433976. Epub 2018 Mar 6.
9
Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis.使用氢交换质谱、物理化学特性分析和结构分析来理解光照暴露的 IgG1 单克隆抗体的聚集倾向增加。
J Pharm Sci. 2018 Jun;107(6):1498-1511. doi: 10.1016/j.xphs.2018.01.017. Epub 2018 Jan 31.
10
Assessment of structural and functional similarity of biosimilar products: Rituximab as a case study.评估生物类似药的结构和功能相似性:以利妥昔单抗为例。
MAbs. 2018 Jan;10(1):143-158. doi: 10.1080/19420862.2017.1402996. Epub 2017 Dec 7.

共价标记和质谱分析揭示抗体治疗药物的细微高级结构变化。

Covalent labeling and mass spectrometry reveal subtle higher order structural changes for antibody therapeutics.

机构信息

a Department of Chemistry , University of Massachusetts Amherst , Amherst , MA , USA.

b QuarryBio Inc ., Bloomington , IN , USA.

出版信息

MAbs. 2019 Apr;11(3):463-476. doi: 10.1080/19420862.2019.1565748. Epub 2019 Feb 6.

DOI:10.1080/19420862.2019.1565748
PMID:30636503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6512938/
Abstract

Monoclonal antibodies are among the fastest growing therapeutics in the pharmaceutical industry. Detecting higher-order structure changes of antibodies upon storage or mishandling, however, is a challenging problem. In this study, we describe the use of diethylpyrocarbonate (DEPC)-based covalent labeling (CL) - mass spectrometry (MS) to detect conformational changes caused by heat stress, using rituximab as a model system. The structural resolution obtained from DEPC CL-MS is high enough to probe subtle conformation changes that are not detectable by common biophysical techniques. Results demonstrate that DEPC CL-MS can detect and identify sites of conformational changes at the temperatures below the antibody melting temperature (e.g., 55 ᴼC). The observed labeling changes at lower temperatures are validated by activity assays that indicate changes in the F region. At higher temperatures (e.g., 65 ᴼC), conformational changes and aggregation sites are identified from changes in CL levels, and these results are confirmed by complementary biophysical and activity measurements. Given the sensitivity and simplicity of DEPC CL-MS, this method should be amenable to the structural investigations of other antibody therapeutics.

摘要

单克隆抗体是制药行业中增长最快的治疗方法之一。然而,检测抗体在储存或处理不当时的高级结构变化是一个具有挑战性的问题。在这项研究中,我们描述了使用基于二乙基焦碳酸盐(DEPC)的共价标记(CL)-质谱(MS)来检测热应激引起的构象变化,以利妥昔单抗为模型系统。从 DEPC CL-MS 获得的结构分辨率足以探测到常见生物物理技术无法检测到的细微构象变化。结果表明,DEPC CL-MS 可以在低于抗体熔化温度(例如 55°C)的温度下检测和识别构象变化的部位。在较低温度下观察到的标记变化通过活性测定得到验证,该测定表明 F 区发生了变化。在较高温度(例如 65°C)下,通过 CL 水平的变化鉴定出构象变化和聚集部位,这些结果通过补充生物物理和活性测量得到证实。鉴于 DEPC CL-MS 的灵敏度和简单性,该方法应该适用于其他抗体治疗药物的结构研究。